BEHIND THE SCENES OF HEALTHTECH VC: MICHAEL CARDAMONE'S PERSPECTIVE

Connect with Ayush on: LinkedIn: https://www.linkedin.com/in/ayushj/ Twitter: https://twitter.com/IM_AyushJain Connect Michael Cardamone on LinkedIn: https://www.linkedin.com/in/michaelcardamone/ You can also find us on social media. So be sure you follow us there as well: Linkedin- https://www.linkedin.com/company/mindbowser-infosolutions/ Facebook- https://www.facebook.com/Mindbowser Instagram- https://www.instagram.com/mindbowser_inc/ Twitter- https://twitter.com/Mindbowser

In this episode of the HealthTech With Purpose podcast, we had a great discussion with Michael Cardamone, CEO & Managing Partner at Forum Ventures (formerly Acceleprise). Michael shares insights into his background, including his time in San Francisco and his experience in the startup ecosystem. He discusses the structure of Forum Ventures, which includes an accelerator, a pre-seed fund, and a venture studio, focusing on early-stage investments, particularly in B2B and health tech sectors. Michael highlights some of the companies they've invested in, such as Remo Health and Finni Health, and explains Forum Ventures' investment strategy, which involves check sizes ranging from $100K to $750K, depending on the stage and engagement level. He notes a recent trend towards normalization in the venture capital landscape, with increasing activity in early-stage funding and a cautious but growing interest from LPs in emerging managers and smaller funds. The conversation touches on the potential of AI in healthcare, particularly in early detection and operational efficiencies, and the challenges of navigating the healthcare market. Michael emphasizes the importance of deep market understanding, strong market validation, and early engagement with key stakeholders like health systems or self-insured employers. He also shares insights into the complexities of selling into health systems and offers advice for health founders on how to become fundable, including the importance of regulatory knowledge and proving product efficacy. The discussion concludes with Michael providing contact information for those interested in reaching out to Forum Ventures.